
CJC-Ipamorelin Blend is a specialized combination of two distinct growth hormone secretagogues: CJC-1295 (without DAC) and Ipamorelin. In research settings, this blend is primarily studied for its ability to act synergistically on the somatotropic axis. By targeting different receptors within the pituitary gland and hypothalamus, this combination is designed to investigate the amplification of pulsatile growth hormone (GH) secretion and its subsequent effects on metabolic and regenerative pathways.